TP53 and small cell lung carcinoma: Interestingly, Nutlin-3a treatment, which enhances p53 stability upon its restoration, promoted cell death induction in both Type V and Type D cells, which could be blunted by CsA treatment in each SCLC type (Supplementary Fig. 6).